Curemark Revenue and Competitors

Rye, NY USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Curemark's estimated annual revenue is currently $4.2M per year.(i)
  • Curemark's estimated revenue per employee is $181,957

Employee Data

  • Curemark has 23 Employees.(i)
  • Curemark grew their employee count by 5% last year.

Curemark's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Chief Staff at CuremarkReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
VP Manufacturing Sciences and TechnologyReveal Email/Phone
5
SVP, Corporate Strategy & FinanceReveal Email/Phone
6
Director Clincal OperationsReveal Email/Phone
7
Senior Director OperationsReveal Email/Phone
8
Medical DirectorReveal Email/Phone
9
AdvisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M30%N/AN/A
#2
N/A2043%N/AN/A
#3
$6.7M33-6%N/AN/A
#4
$34.4M222-1%N/AN/A
#5
$5.2M670%$10MN/A
#6
$2M130%N/AN/A
#7
$7.5M370%$51.6MN/A
#8
$0.3M1-50%N/AN/A
#9
$4.3M21-16%$3.3MN/A
#10
$3.6M205%N/AN/A
Add Company

What Is Curemark?

Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$4.2M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Curemark News

2022-04-17 - How being more flexible can benefit your life, career

Joan Fallon is the founder and CEO of Curemark, and is considered a visionary scientist who has dedicated her life's work to championing the...

2022-04-13 - Autism Spectrum Disorder Diagnostics Market Size, Scope ...

Autism Spectrum Disorder Diagnostics Market Size, Scope And Forecast | Leading Players – Pfizer, Merck, Roche, SynapDx, Curemark.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M259%N/A
#2
$7M25-14%N/A
#3
$5.5M264%N/A
#4
N/A2717%N/A
#5
$3.5M3365%N/A